China Medical posts record sales as drug portfolio expands
|
|
China Medical Systems Holdings, the Chinese pharmaceutical distribution, marketing and research of the company, saw at the impressive increase in turnover and pre-tax profits during the year 2007 as a result of the class Listing on the AIM, the market last June. Mr. Lam Kong, the company’s Chairman and Chief Executive, said CMS has been considerable progress since its successful initial public offering of its distribution and trading income and R & D department. He said: “In line with the strategy, at the time of our IPO, we have three new drugs exclusive distribution portfolio, which have already started to contribute to revenues. In addition, more than one license, two products were, since the end of the year. During the year to 31 December 2007, the China Medical turnover record of $ 51.7 million (£ 26.1 million) to 38%. The profit before tax increased by 10.3 million from US $ 5.4 million in the last quarter. |